Fig. 5From: Surface modification of cobalt oxide nanoparticles using phosphonomethyl iminodiacetic acid followed by folic acid: a biocompatible vehicle for targeted anticancer drug deliveryFluorescence image of the RhB-DOX-FA-PMIDA-CoO/RhB-MTX-FA-PMIDA-CoO-treated KB (a, b) and KG1a (c, d) cell lines. Phagocytic activity of macrophage with incubation with RhB-PMIDA-CoO/RhB-FA-PMIDA-CoO (e, f)Back to article page